The University of Vermont Medical Center Thrombosis and Hemostasis Program
Laboratory for Clinical Biochemistry Research
The care of patients with venous thrombosis and its complications, with an emphasis on personalized approaches. Evaluation and management of patients with premature or unexplained arterial vascular disease and the role of novel risk factors in management. Optimization of the quality of acute and chronic administration of anticoagulant medications for treatment and prevention of thrombosis.
• Epidemiological studies to elucidate hypotheses on etiology and pathogenesis of cardiovascular diseases (myocardial infarction, stroke, and venous thrombosis).
• The role of the cardiovascular system in determining brain health, in particular the vascular origins of cognitive impairment.
• The role of disorders of coagulation in venous and arterial thrombotic disease, and the prevention and treatment of these disorders.
• Understanding causes of racial disparities in stroke, cognitive impairment and cardiovascular risk factors
1996 M.Sc., Epidemiology, Harvard University, School of Public Health, Boston, Massachusetts
1989 M.D., University of Vermont College of Medicine, Burlington, Vermont
1985 B.S. (cum laude), Biology, University of Vermont, Burlington, Vermont
1992 - 1995 Fellow in Hematology, Department of Medicine, University of Vermont and Fletcher Allen Health Care, Burlington, Vermont
1993 - 1995 Research Fellow in Hemostasis, Department of Pathology, University of Vermont, Burlington, Vermont
1989 - 1992 Resident in Internal Medicine, Traditional Track, Department of Medicine, Medical Center Hospital of Vermont, Burlington, Vermont
2019 – present Board Director, Eastern States Affiliate, American Heart Association
2019 - present Board Director, Hemophilia and Thrombosis Research Society
2016 - present Inaugural Editor-in Chief, Research and Practice in Thrombosis and Haemostasis (RPTH)
2017 – present Council Member (non-voting), International Society on Thrombosis and Haemostasis
2013 - present Board Director,Cardiovascular Research Institute , University of Vermont
2013 - 2015 Board Director, American Heart Association
2012 - 2014 Chair, American Heart Association Council Operations Committee
2000-2017 Leadership Committee, American Heart Association Council on Epidemiology and Prevention (chair 2008-10)
2019 University Scholar – University of Vermont
2019 Mentor Award, Department of Medicine, University of Vermont
2019 Highly Cited Researcher – top 1% in Clinical Medicine, Clarivate Analytics
2018 Population Research Prize, American Heart Association
2018 Highly Cited Researcher – top 1% in Clinical Medicine, Clarivate Analytics
2014 Distinguished Achievement Award, American Heart Association Council on Epidemiology and Prevention
2012 Senior Researcher of the Year, UVM Medical Center
2009 Distinguished Academic Achievement Award. University of Vermont College of Medicine Alumni Association.
“Venous Thrombosis Risk during and after Medical and Surgical Hospitalizations: The Medical Inpatient Thrombosis and Hemostasis (MITH) Study.” Bruno XJ, Koh I, Lutsey PL, Walker RF, Roetker NS, Wilkinson K, Smith NL, Plante TB, Repp AB, Holmes CE, Cushman M, Zakai NA. J Thromb Haemost. 2022 Apr 15. doi: 10.1111/jth.15729
“Collaborative Cohort of Cohorts for COVID-19 Research (C4R) Study: Study Design.”
Oelsner EC, Krishnaswamy A, Balte PP, Allen NB, Ali T, Anugu P, Andrews H, Arora K, Asaro A, Barr RG, Bertoni AG, Bon J, Boyle R, Chang AA, Chen G, Coady S, Cole SA, Coresh J, Cornell E, Correa A, Couper D, Cushman M, Demmer RT, Elkind MSV, Folsom AR, Fretts AM, Gabriel KP, Gallo L, Gutierrez J, Han MLK, Henderson JM, Howard VJ, Isasi CR, Jacobs DR Jr, Judd SE, Mukaz DK, Kanaya AM, Kandula NR, Kaplan R, Kinney GL, Kucharska-Newton A, Lee JS, Lewis CE, Levine DA, Levitan EB, Levy B, Make B, Malloy K, Manly JJ, Mendoza-Puccini C, Meyer KA, Min YI, Moll M, Moore WC, Mauger D, Ortega VE, Palta P, Parker MM, Phipatanakul W, Post WS, Postow L, Psaty BM, Regan EA, Ring K, Roger VL, Rotter JI, Rundek T, Sacco RL, Schembri M, Schwartz DA, Seshadri S, Shikany JM, Sims M, Hinckley Stukovsky KD, Talavera GA, Tracy RP, Umans JG, Vasan RS, Watson K, Wenzel SE, Winters K, Woodruff PG, Xanthakis V, Zhang Y, Zhang Y, C R Investigators FT. Am J Epidemiol. 2022 Mar 12:kwac032. doi: 10.1093/aje/kwac032
“Association between cardiovascular risk factors and venous thromboembolism in the elderly.” Wang H, Rosendaal FR, Cushman M, van Hylckama Vlieg A. Res Pract Thromb Haemost. 2022 Mar 1;6(2):e12671. doi: 10.1002/rth2.12671
“C-reactive protein and racial differences in type 2 diabetes incidence: The REGARDS study.” Peper KM, Guo B, Long DL, Howard G, Carson AP, Howard VJ, Judd SE, Zakai NA, Cherrington A, Cushman M, Plante TB. J Clin Endocrinol Metab. 2022 Feb 8:dgac074. doi: 10.1210/clinem/dgac074.
“Atrial Fibrillation and Stroke Symptoms in the REGARDS Study.” Reading Turchioe M, Soliman EZ, Goyal P, Merkler AE, Kamel H, Cushman M, Soroka O, Masterson Creber R, Safford MM. J Am Heart Assoc. 2022 Jan 18;11(2):e022921. doi: 10.1161/JAHA.121.022921
“Alpha Globin Gene Copy Number Is Associated with Prevalent Chronic Kidney Disease and Incident End-Stage Kidney Disease among Black Americans.” Ruhl AP, Jeffries N, Yang Y, Naik RP, Patki A, Pecker LH, Mott BT, Zakai NA, Winkler CA, Kopp JB, Lange LA, Irvin MR, Gutierrez OM, Cushman M, Ackerman HC. J Am Soc Nephrol. 2022 Jan;33(1):213-224. doi: 10.1681/ASN.2021050653.
“Health care experiences during the COVID-19 pandemic by race and social determinants of health among adults age?=?58?years in the REGARDS study.” Levitan EB, Howard VJ, Cushman M, Judd SE, Tison SE, Yuan Y, Kamin Mukaz D, Wang HE, Pamir N, Plante TB, Juraschek SP, Safford MM, Goyal P. BMC Public Health. 2021 Dec 11;21(1):2255. doi: 10.1186/s12889-021-12273-8.
“Thrombo-inflammatory biomarkers and D-dimer in a biracial cohort study.” Kamin Mukaz D, Gergi M, Koh I, Zakai NA, Judd SE, Sholzberg M, Baumann Kreuziger L, Freeman K, Colovos C, Olson NC, Cushman M. Res Pract Thromb Haemost. 2021 Dec 7;5(8):e12632. doi: 10.1002/rth2.1263
“Associations of Plasma Biomarkers of Inflammation, Fibrosis, and Kidney Tubular Injury With Progression of Diabetic Kidney Disease: A Cohort Study.” Gutiérrez OM, Shlipak MG, Katz R, Waikar SS, Greenberg JH, Schrauben SJ, Coca S, Parikh CR, Vasan RS, Feldman HI, Kimmel PL, Cushman M, Bonventre JV, Sarnak MJ, Ix JH. Am J Kidney Dis. 2021 Nov 6:S0272-6386(21)00956-2. doi: 10.1053/j.ajkd.2021.09.018
“Cardiovascular damage phenotypes and all-cause and CVD mortality in older adults.”
Miller LM, Wu C, Hirsch CH, Lopez OL, Cushman M, Odden MC. Ann Epidemiol. 2021 Nov;63:35-40. doi: 10.1016/j.annepidem.2021.07.012
For a complete list of Mary Cushman's publications, please visit Google Scholar